We are uniquely positioned to deliver on our mission of empowering people worldwide to live healthier at every stage of life. As a global healthcare company, improving access and sustainably delivering high-quality medicine is our relentless pursuit.
For more information, visit http://www.viatris.com/en
Mini-audit: Pancreatic exocrine insufficiency (PEI)
In this clinical audit you will conduct a review of patients with pancreatic exocrine insufficiency (PEI) who are currently receiving PERT (pancreatic enzyme replacement therapy), in order to assess their quality of life and treatment effectiveness, and optimise their therapy.
